Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Download PDF

Malondialdehyde (MDA) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in ischemic stroke: a systematic review

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery volume 59, Article number: 87 (2023) Cite this article

Abstract

Introduction

The low blood flow in ischemic stroke reduces oxygen and glucose and induces a series of reactions that produce free radicals. Free radicals can destroy cell membranes (lipid peroxidation) marked by the elevation of malondialdehyde (MDA), and the damage of deoxyribonucleic acid (DNA) showed by the elevation of 8-hydroxy-2’-deoxyguanosine (8-OHdG). This review aimed to assess and conclude the research-based study systematically to analyze the relationship of MDA/8-OHdG and ischemic stroke.

Method

Cochrane handbook for systematic reviews, the guideline of preferred reporting items for systematic review and meta-analysis (PRISMA), and synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline was used as guideline in this systematic review. Inclusion criteria in this review were primary studies of every design, articles published in English around January 2000–December 2021, and the study used human as subject. A systematic literature search was applied in 15 electronic medical journals. The authors assessed the study quality and risk of bias of each included study.

Results

The authors evaluated 374 studies found in literature searching, 30 studies met the criteria for this review, and then underwent the assessment of study quality and risk of bias.

Conclusion

MDA has the role as oxidative stress biomarker, outcome predictor, mortality predictor, post-stroke cognitive impairment predictor, post-stroke depression predictor, and hand grip strength predictor of ischemic stroke; while 8-OHdG has the role as oxidative stress biomarker, outcome predictor, mortality predictor, post-stroke cognitive impairment predictor, post-stroke depression predictor of ischemic stroke.

Introduction

Stroke is a significant contributor to morbidity, disability, and mortality in the world [1,2,3]. American Heart Association (AHA) reported the mortality rate of stroke increased about 0.7 per 100.000 from 2010 to 2016 in 35–64 years of age; while Centers for Disease Control and Prevention (CDC) reported that every 4 min someone dies due to stroke, and stroke also reduces mobility in more than 50% of stroke geriatric survivors [4, 5]. Ischemic stroke is the frequent stroke (approximately 80% of stroke) caused by impaired perfusion to the brain [4,5,6,7,8].

Oxidative (and nitrosative) stress is described as a disproportion of pro-oxidants (such as free radicals) and antioxidants, which has been associated with the pathogenesis of several chronic disorders such as ischemic stroke due to the dysfunction of blood–brain barrier (BBB) and neuronal degeneration and apoptosis [9,10,11]. Oxidative (and nitrosative) stress has an essential role in ischemic stroke through several actions. The low blood flow in ischemic stroke reduces the oxygen and glucose and induces a series of reactions that produce free radicals (reactive oxygen species (ROS) and reactive nitrogen species (RNS)). Free radical has various roles including as a part of vascular regulatory system, oxygen pressure monitoring, and erythropoietin generation in small levels, but abundant levels of free radicals may oxidize macromolecules and lead to lethal cell damage (neuronal death and brain edema) [9,10,11,12]. Excitotoxic injury induces superoxide and nitric oxide (NO) generation, inducing the production of highly reactive products, including peroxynitrite and hydroxyl radicals, which can destroy lipids, proteins, and DNA [13]. The brain is particularly endangered to oxidative stress because of the high level of fatty acids cell membranes, its high rate of oxidative metabolic activity and potent generation of free radical (basal oxygen consumption), lower neuronal antioxidant capacity, and elevated concentration of iron (which acts to catalyze the conversion of H2O2 to highly reactive hydroxyl radicals) [14,15,16].

Free radicals can damage cell membrane (lipid peroxidation) marked by the elevation of malondialdehyde (MDA), and the damage of deoxyribonucleic acid (DNA) showed by the elevation of 8-hydroxy-2′-deoxyguanosine (8-OHdG). MDA is one of the aldehyde molecules product due to the breakage of polyunsaturated fatty acids chains in the cell membrane, while 8-OHdG is formed by the interaction of free radicals and guanine (nitrogen base in DNA) [17]. Haritha et al. (2020) reported the elevation of MDA level in ischemic stroke, while Elsayed et al. (2020) reported the correlation of MDA level and clinical outcome of ischemic stroke [18, 19]. Syafrita et al. (2020) reported that MDA and 8-OHdG were associated with depression post-stroke [10]. The role of biomarker in ischemic stroke is important, especially in hospitals with limited neuroimaging facilities.

MDA and 8-OHdG in ischemic stroke have been presented in different studies, but a systematic review about this topic was not available. The current systematic review aimed to evaluate and conclude the research-based study systematically to assess the relationship of MDA/8-OHdG and ischemic stroke.

Methods

This study’s protocol was recorded on International Prospective Register of Systematic Reviews (PROSPERO) (CRD42022289876). This review was conducted in accordance to Cochrane handbook for systematic reviews and the guideline of preferred reporting items for systematic review and meta-analysis (PRISMA) [20, 21]. The data collection and analysis (synthesis) were also conducted based on synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline [22].

Inclusion and exclusion criteria

Inclusion criteria:

  1. 1.

    Publication type:

  • full-text manuscripts reported the relationship of MDA/8-OHdG and ischemic stroke

  • Experimental study (clinical trial) and observational study [descriptive study (case report and case series) and analytical studies (cross-sectional, case–control, and prospective study)]

  1. 2.

    Articles published in English

  2. 3.

    Articles published in January 2000–December 2021

  3. 4.

    The study used human as subject

  4. 5.

    Objective, methodology, and outcome of study must discuss the relationship of MDA/8-OHdG and ischemic stroke.

Exclusion criteria:

  1. 1.

    Publication type was review

  2. 2.

    Variables that were associated with the relationship of MDA/8-OHdG and ischemic stroke.

Literature search

A systematic literature searching was used in these online medical bibliographic databases: Cambridge Core, Clinical Key, Cochrane, Ebsco, Embase, Emerald Insight, Google Scholar, JSTOR, Medline, Nature, Proquest, Pubmed, Science Direct, Scopus, and Springer Link. The search was performed using the following keywords for the title and abstract: (malondialdehyde OR MDA OR 8-hydroxy-2′-deoxyguanosine OR 8-OHdG OR 8-oxo-7,8-dihydro-2′-deoxyguanosine OR 8-OHdG) AND (ischemic stroke OR infarct stroke OR thrombotic stroke OR embolic stroke). The references from included studies were evaluated to avoid the loss of any published article.

Data collection and analysis

Articles were chosen for assessment after two authors (DT and AP) had checked keywords from the online medical bibliographic databases. The results of the literature search were deliberated with third author (RR), and any discrepancies of results were discussed. Selected full-papers were independently evaluated by the other authors (YA and AK). Selected articles for this systematic review were checked by two authors independently to confirm the results (RA and JB). The data from included articles were provided in a summary table, containing key points of each study. The key points of each study were: first author and country; study design; sample characteristic; management/outcome measure; and outcome/result.

Quality assessment

The first author assessed the study quality and risk of bias of each retrieved article and discussed them with other authors. Newcastle–Ottawa scale for prospective study was used to evaluate the quality and risk of bias of prospective study; interpretation of total score was: ≥ 7 points were considered in good studies, 5–6 points were considered in fair studies, < 5 points were considered in poor studies. Newcastle–Ottawa scale for case control study was applied to assess case control study; interpretation of total score was: ≥ 7 points were included in good studies, 5–6 points were included in fair studies, < 5 points were included in poor studies. Newcastle–Ottawa scale adapted for cross-sectional study was used to evaluate the quality and risk of bias of the cross-sectional study. Interpretation of total score was: 9–10 points were included in very good studies, 7–8 points were included in good studies, 5–6 points were included in satisfactory studies, and 0–4 points were included in unsatisfactory studies [23,24,25,26,27].

Results

Selection of articles for review

Figure 1 provides PRISMA flow diagram. At first, 364 peer-reviewed studies were found from online databases and an additional 10 studies were identified through other sources (search engine). After duplicates were eliminated, 212 studies remained for the title and abstract screening. Articles that did not meet the inclusion and exclusion criteria were not evaluated. Thirty-six articles were evaluated for eligibility of which 30 articles were included in this review.

Fig. 1
figure 1

PRISMA flow diagram

Full size image

Assessment of study validity (quality assessment and risk of bias)

All included articles were associated to MDA/8-OHdG and ischemic stroke. Table 1 presents quality scores for prospective studies and the studies had 5–9 points (fair and good study). Table 2 presents quality scores for case–control studies and the studies had 8–9 points (good study). Table 3 presents quality scores for cross-sectional studies and all of the studies had 8 points (good study).

Table 1 Newcastle–Ottawa scale (prospective study)
Full size table
Table 2 Newcastle–Ottawa scale (case–control study)
Full size table
Table 3 Newcastle–Ottawa scale adapted for cross-sectional study
Full size table

Study characteristic

The study characteristics for the included studies are shown in Table 4. Most of the studies were prospective studies and discussed about oxidative stress biomarker of acute ischemic stroke (AIS).

Table 4 Study characteristic
Full size table

Discussion

The role of oxidative stress in ischemic stroke

AIS induces the generation of free radicals through various mechanisms, including the stimulation of N-methyl-d-aspartate (NMDA) receptors, induction of neuronal nitric oxide synthase or cyclooxygenase (COX) 2, auto-oxidation of catecholamines metabolism of free fatty acids during ischemia, the generation of xanthine dehydrogenase to xanthine oxidase, mitochondrial impairment, and BBB disruption that cause migration of neutrophils and leukocytes [31, 39, 49].

O2−, H2O2, OH− are the principal route of the generation of ROS through the reduction of molecular oxygen. Oxidative stress is the result of uncontrolled ROS formation because of oxygen metabolism, oxygen reperfusion injury from hypoxic condition, and also hemoglobin and myoglobin oxidation. The condition of free radicals will cause the brain to consume more lipid, increases oxygen demand, and induces the oxidation of dopamine and glutamate. Additionally, the level of catalase enzyme in the neurons will decline, causing impairment of glutathione peroxidase ability to eradicate H2O2. ROS is a hazardous final product of oxidative phosphorylation and reperfusion injury, because it could cause cellular redox which will affect the activity of protein–protein bond and DNA–protein bond of certain enzymes and transcription factors [50]. The other effects of ROS actions are altered function of receptors, ion channels, and other membrane proteins; that damage cell membrane fluidity and permeability, cause lipid peroxidation, protein denaturation, nucleic acid and DNA damage, damage to cytoskeletal structure, and chemotaxis [49, 51]. When brain contains abundant polyunsaturated fatty acids, ROS could easily elevate lipid peroxidation. Lipid peroxidation can also be activated by non-radical ROS, especially in acidic conditions, including during ischemic stroke. Lipid peroxidation can change membrane instability and permeability, as well as the function of ion pumps on the membrane border. This condition will endanger ion homeostasis, and can lead to loss of membrane integrity and cell injury. Lipid peroxidation can also induce disintegration of pro-inflammatory isoprostanoid mediator which is highly dangerous and release strong oxidant like 4-hydroxynonenal (4-HNE) [50].

The importance of oxidative stress in ischemic stroke pathophysiology make the use of antioxidants became pivotal to provide protection from neurological impairment. Oxidative stress states occur when cellular antioxidant defenses are inadequate to sustain the level of free radicals under a lethal threshold. This may be due to uncontrolled generation of free radicals or the failure of antioxidant defenses, or both [44, 47]. The extensive lesion of oxidative stress damage is also dependent on the antioxidant defense mechanism (including antioxidant enzymes such as SOD, catalase, and glutathione peroxidase; and antioxidant non-enzymatic such as retinol, ascorbic acid, α-tocopherol, carotenoid, and uric acid) [18, 39]. In severe stroke, antioxidants cannot balance the huge free radicals due to the larger neurological damage lesion. The antioxidant enzymes are inducible enzymes, so the transcription and production take time [18]. Agents that can prevent or decrease the effect of oxidative stress and reduce the number of cell damage in stroke are called neuroprotective drugs, such as edaravone, tirilazad, citicoline, etc. [50, 52].

MDA and 8-OHdG in ischemic stroke

There were 30 studies that reported the use of MDA and 8-OHdG as ischemic stroke biomarkers. MDA and 8-OHdG were commonly used as biomarkers of oxidative stress in various diseases including stroke. They were the final result of oxidative stress process because of the degradation of cellular organelles. After the release of MDA and 8-OHdG into the extracellular space, it reached the CSF and blood; therefore, it had been applied as a reliable biomarker of oxidative stress [14]. Urinary 8-OHdG was also deliberated as a pivotal biomarker of oxidative stress because oxidized DNA (8-OHdG) was water-soluble and excreted into the urine without being further metabolized [16].

The different pathophysiology of lacunar infarction (small-vessel) and large-vessel infarction stroke make the difference of MDA and 8-OHdG levels in each type. The pathogenesis of lacunar infarction is lipohyalinosis, while atherothrombosis is the major cause of large-vessel infarction; and the stress oxidative level was higher in large-vessel infarction due to the infarction volume [12, 39]. The number of risk factors in each type of ischemic stroke also affects the level of oxidative stress [12].

The lipid peroxidation due to acute ischemia; and conversion of xanthine dehydrogenase to xanthine oxidase and protein kinase activation (due to the activation of phospholipase and protease because of the elevation of cytosolic calcium) are the main cause of MDA elevation in AIS [9, 31, 39, 49]. The reason for high MDA concentration in chronic stroke is associated with risk factors and/or atherosclerosis itself; although the concentration of oxidative stress is lower than acute stroke (due to the antioxidant effect and disease course) [41, 44]. Elevation peroxidation results are associated with red blood cell aggregation, and also initiate NADPH-oxidase complex in phagocytes and activate stages of events leading to elevated uptake of low-density lipoprotein by macrophages, and finally leading to the generation of foam cells. By these mechanisms, lipid peroxides are associated with the pathophysiology of atherosclerosis [41].

Six studies focused on the importance of MDA and 8-OHdG in predicting ischemic stroke outcome [9, 12, 18, 38, 39, 42]. Lipid peroxidation due to misfolding of a-synuclein had a pivotal role in neuronal cell death. ROS due to lipid peroxidation could trigger p53 signaling cascade; impaired cell membrane (the damage of ion transport proteins and regulatory systems), induced functional damage of mitochondrial and DNA, and inhibited nucleotide excision repair system [17, 53]. The interaction of MDA and protein and nucleic acid could cause permanent impairment of the enzymes, receptors, and membrane transfer mechanisms [9, 14]. There was an abundant production of MDA and 8-OHdG through ischemia in the penumbral tissue which had minimal oxygen supply (secondary enlargement of brain impairment after focal cerebral ischemia). In the first phase of ischemic stroke, there was an increase of MDA and 8-OHdG because of the failure of defense mechanisms of oxidative stress, that considered from the volume of tissue damage, stroke severity, and outcome [12, 17, 18]. Three studies explained about the role of MDA and 8-OHdG as mortality biomarker in ischemic stroke [33,34,35]. Lorente et al. reported that MDA level (> 2.27 nmol/mL) and 8-OHdG level (> 4.82 ng/mL) were associated with 30-day mortality of IS patients [33, 35].

Three studies reported about the importance of MDA and 8-OHdG in detecting post-stroke depression (PSD) [10, 11, 17]. Liu et al. (2018) reported that 8-OHdG level above 200 ng/L was positively correlated with PSD [11]. PSD was the most frequent neuropsychiatric disorder after stroke (the prevalence was 29–35%) and was associated with worse functional outcome [53]. Oxidative stress could induce the dysregulation of hypothalamus–pituitary–adrenal axis, affected into the stress control; and the other factors such as age, lifestyle, alcohol, and smoking also contribute in the PSD [10, 11]. Oxidative stress changed the chemical structure of endogenous fatty acids, and produced immunogenic neoepitopes that could induce secondary immune responses, activates indolamine 2,3-dioxygenase and tryptophan catabolites that decreased serotonin level; thus link to depression [53]. Liu et al. (2017) reported about the association of MDA and 8-OHdG and post-stroke cognitive impairment (PSCI); and concluded that MDA (> 2.59 nmol/mL) and 8-OHdG (> 158.63 ng/L) level were associated with PSCI. Vascular inflammation, neurodegeneration, and BBB disruption (extravasation of oxidative stress products) were the main pathophysiology of this association due to hypoxia–ischemia brain cell. Additionally, oxidative stress could promote impairment of peroxisome proliferator-activated receptor (PPAR-γ), a condition that was correlated with vascular aging, neuroinflammation, cerebrovascular white matter lesion, and cognitive impairment [17]. Mueangson et al. (2020) reported about the use of MDA as low hand grip strength (HGS) biomarker in stroke patients. HGS was known as reliable parameter in muscle strength measurement after stroke. The elevation of lipid peroxide and MDA levels were associated with the production by peripheral cells, extracellular generation of hydrogen peroxide by paretic muscles during denervation and associated comorbidities (diabetes, hypertension, and dyslipidemia) [45].

Strength and limitation of the study

This systematic review consisted of 30 studies that discussed the relationship of MDA/8-OHdG and ischemic stroke. The majority of the studies discussed oxidative stress biomarker of acute ischemic stroke.

The limitation of the study was all of the studies were observational, the baseline characteristics were various, the variance of the demography in the human study, confounding variables in each study (human study), sample size, and limited follow-up time.

Future implication

The current systematic review can be a scientific publication to physicians, researchers, and all of the readers associated with the relationship of MDA/8-OHdG and ischemic stroke. Further research is needed with the larger sample size with diverse demographic variances and longer follow-up time, the comparison of these biomarkers with gold standard examination (such as neuroimaging), and also the role of these biomarkers in ischemic stroke treatment.

Conclusion

MDA has the role as oxidative stress biomarker, outcome predictor, mortality predictor, post-stroke cognitive impairment predictor, post-stroke depression predictor, and hand grip strength predictor of ischemic stroke; while 8-OHdG has the role as oxidative stress biomarker, outcome predictor, mortality predictor, post-stroke cognitive impairment predictor, post-stroke depression predictor of ischemic stroke.

Availability of data and materials

All data generated or analysed during this study are included in this published article.

References

  1. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke. 2019;50:344–418.

    Article  Google Scholar 

  2. Donkor ES. Stroke in the 21st Century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018;1–10.

  3. Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38:208–11.

    Article  PubMed  Google Scholar 

  4. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart Disease and Stroke Statistics-2021 Update A Report from the American Heart Association. Circulation. 2021;141(9):E254-743.

    Google Scholar 

  5. CDC. Stroke Facts [Internet]. 2021 [cited 2021 Oct 30]. Available from: https://www.cdc.gov/stroke/facts.htm.

  6. Hossmann K-A, Heiss W-D. Neuropathology and pathophysiology of stroke. Cambridge: Cambridge University Press; 2019.

    Book  Google Scholar 

  7. Chen L, Yang Q, Ding RUI, Liu DAN, Chen Z. Carotid thickness and atherosclerotic plaque stability, serum inflammation, serum mmp-2 and mmp-9 were associated with acute cerebral infarction. Exp Ther Med. 2018;16(6):5253–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Simats A, García-Berrocoso T, Montaner J. Neuroinflammatory biomarkers: from stroke diagnosis and prognosis to therapy. Biochim Biophys Acta Mol Basis Dis. 2016;1862(3):411–24.

    Article  CAS  Google Scholar 

  9. Shaafi S, Hadisi F, Mahmoudinezhad M, Razmi H, Nejadghaderi SA, Khalili M. The significance of the oxidative stress markers in the one-year prognosis of patients with acute ischemic stroke: a case-control study. BMC Neurol. 2021;21(258):1–8.

    Google Scholar 

  10. Syafrita Y, Amir D, Susanti R, Fadhilah I. Relationship of brain-derived neurotrophic stroke depression. Dement Neuropsychol. 2020;14(1):41–6.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Liu Z, Cai Y, He J. High serum levels of 8-OHDG are an independent predictor of post-stroke depression in Chinese stroke survivors. Neuropsychiatr Dis Treat. 2018;14:587–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Nakajima H. The relation of urinary 8-OHdG, a marker of oxidative stress to DNA, and clinical outcomes for ischemic stroke. Open Neurol J. 2012;6:51–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Aygul R, Kotan D, Demirbas F, Ulvi H, Deniz O. Plasma oxidants and antioxidants in acute ischaemic stroke. J Int Med Res. 2006;34:413–8.

    Article  CAS  PubMed  Google Scholar 

  14. Menon B, Ramalingam K, Kumar R. Evaluating the role of oxidative stress in acute ischemic stroke. J Neurosci Rural Pract. 2020;11(1):156–9.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke. 2020;1891–5.

  16. Milanlioglu A, Aslan M, Ozkol H, Çilingir V, Nuri Aydın M, Karadas S. Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcome. Wien Klin Wochenschr. 2016;128(5–6):169–74.

    Article  CAS  PubMed  Google Scholar 

  17. Liu Z, Liu Y, Tu X, Shen H, Qiu H, Chen H, et al. High serum levels of malondialdehyde and 8-OHdG are both associated with early cognitive impairment in patients with acute ischaemic stroke. Sci Rep. 2017;7:1–8.

    Google Scholar 

  18. Elsayed WM, Abdel-Gawad EHA, Mesallam DIA, El-Serafy TS. The relationship between oxidative stress and acute ischemic stroke severity and functional outcome. Egypt J Neurol Psychiatry Neurosurg. 2020;56(74):1–6.

    Google Scholar 

  19. Haritha B, Sangeetha B. Malondialdehyde levels in ischemic stroke. IOSR-JDMS. 2020;19(5):36–41.

    Google Scholar 

  20. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:1–9.

    Google Scholar 

  21. Higgins J, Green S. Cochrane handbook for systematic reviews of intervention 5.2. United Kingdom: John Wiley and Sons; 2017. p. 1–50.

    Google Scholar 

  22. Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:1–6.

    Google Scholar 

  23. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2019.

  24. Herzog R, Álvarez-pasquin MJ, Díaz C, Luis J, Barrio D, Estrada JM, et al. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013;13(154):1–17.

    Google Scholar 

  25. Viswanathan M, Ansari MT, Berkman ND, Chang S, Hartling L, McPheeters M, et al. Methods guide for effectiveness and comparative effectiveness reviews, assessing the risk of bias of individual studies in systematic reviews of health care interventions. USA: AHRQ Publication; 2008.

    Google Scholar 

  26. Islam M, Iqbal U, Walther B, Atique S, Dubey N, Nguyen P, et al. Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology. 2016;47:181–91.

    Article  PubMed  Google Scholar 

  27. Luchini C, Stubbs B, Solmi M, Veronese N. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa scale. World J Meta-Anal. 2017;5(4):80–4.

    Article  Google Scholar 

  28. Atiba AS, Olawuyi AO, Akande JO, Niran-Atib TA, Bello N, Oparinde DP. Association of a product of free radical injury with parameters of lipid profile in patients with stroke. J Med Sci. 2020;20(2):44–8.

    Article  CAS  Google Scholar 

  29. Aygül R, Kotan D, Yildirim A, Ulvi H, Akçay F. Plasma and cerebrospinal fluid homocysteine, nitric oxide and malondialdehyde levels in acute ischemic stroke: possible role of free radicals in the development of brain injury. Eur J Gen Med. 2008;5(2):57–63.

    Google Scholar 

  30. Cano CP, Bermúdez VP, Atencio HE, Medina MT, Anilsa A, Souki A, et al. Increased serum malondialdehyde and decreased nitric oxide within 24 hours of thrombotic stroke onset. Am J Ther. 2003;10:473–6.

    Article  PubMed  Google Scholar 

  31. Cojocaru IM, Cojocaru M, Sapira V, Ionescu A. Evaluation of oxidative stress in patients with acute ischemic stroke. Rom J Intern Med. 2013;51(2):97–106.

    CAS  PubMed  Google Scholar 

  32. Domínguez C, Delgado P, Vilches A, Martín-Gallán P, Ribó M, Santamarina E, et al. Oxidative stress after thrombolysis-induced reperfusion in human stroke. Stroke. 2010;41(4):653–60.

    Article  PubMed  Google Scholar 

  33. Lorente L, Martín MM, Abreu-González P, Ramos L, Argueso M, Solé-Violán J, et al. Serum malondialdehyde levels in patients with malignant middle cerebral artery infarction are associated with mortality. PLoS ONE. 2015;10(5):1–9.

    Article  Google Scholar 

  34. Lorente L, Martín MM, Pérez-Cejas A, Abreu-González P, Ramos L, Argueso M, et al. Association between total antioxidant capacity and mortality in ischemic stroke patients. Ann Intensive Care. 2016;6(39):1–6.

    CAS  Google Scholar 

  35. Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Ramos L, et al. DNA and RNA oxidative damage are associated to mortality in patients with cerebral infarction. Med Intensiva. 2021;45(1):35–41.

    Article  CAS  PubMed  Google Scholar 

  36. Lorenzano S, Rost NS, Khan M, Li H, Lima FO, Maas MB, et al. Oxidative stress biomarkers of brain damage: hyperacute plasma F2-isoprostane predicts infarct growth in stroke. Stroke. 2018;49(3):630–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Mizukoshi G, Katsura K, Katayama Y. Urinary 8-hydroxy-2′-deoxyguanosine and serum S100β in acute cardioembolic stroke patients. Neurol Res. 2005;27:644–6.

    Article  CAS  PubMed  Google Scholar 

  38. Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic Res. 2002;36(3):265–8.

    Article  CAS  PubMed  Google Scholar 

  39. Tsai N-W, Chang Y-T, Huang C-R, Lin Y-J, Lin W-C, Cheng B-C, et al. Association between oxidative stress and outcome in different subtypes of acute ischemic stroke. Biomed Res Int. 2014;1–7.

  40. Zimmermann C, Winnefeld K, Streck S, Roskos M, Haberl RL. Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol. 2004;51:157–61.

    Article  CAS  PubMed  Google Scholar 

  41. Bir LS, Demir S, Rota S, Köseoǧlu M. Increased serum malondialdehyde levels in chronic stage of ischemic stroke. Tohoku J Exp Med. 2006;208:33–9.

    Article  CAS  PubMed  Google Scholar 

  42. Demirkaya S, Topcuoglu MA, Aydin A, Ulas UH, Isimer AI, Vural O. Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur J Neurol. 2001;8:43–51.

    Article  CAS  PubMed  Google Scholar 

  43. Dogan O, Kisa U, Erdemoglu AK, Kacmaz M, Caglayan O, Kurku H. Oxidative and nitrosative stress in patients with ischemic stroke. J Lab Med. 2018;42(5):195–200.

    CAS  Google Scholar 

  44. Moon GJ, Kim SJ, Cho YH, Ryoo S, Bangc OY. Antioxidant effects of statins in patients with Atherosclerotic Cerebrovascular Disease. J Clin Neurol. 2014;10(2):140–7.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Mueangson O, Vongvaivanichakul P, Kamdee K, Jansakun C, Chulrik W, Pongpanitanont P, et al. Malondialdehyde as a useful biomarker of low hand grip strength in community-dwelling stroke patients. Int J Environ Res Public Health. 2020;17(21):1–12.

    Article  Google Scholar 

  46. Sarkar PD, Rautaray SS. A study of serum malondialdehyde levels and paraoxanase activity in ischemic stroke patients. Biomed Res. 2009;20(1):64–6.

    CAS  Google Scholar 

  47. Yildirim A, Kotan D, Yildirim S, Aygül R, Akçay F. Increased lipid peroxidation and decreased antioxidant response in serum and cerebrospinal fluid in acute ischemic stroke. Turk J Med Sci. 2007;37(2):75–81.

    CAS  Google Scholar 

  48. Chen C-Y, Chen C-L, Yang Y-H, Ho C-H, Tseng W-C. Poststroke depressive symptoms are associated with increased oxidative deoxyribonucleic acid damage. J Neuropsychiatry Clin Neurosci. 2018;30(2):139–44.

    Article  PubMed  Google Scholar 

  49. Maciejczyk M, Bielas M, Zalewska A, Gerreth K. Salivary biomarkers of oxidative stress and inflammation in stroke patients: from basic research to clinical practice. Oxid Med Cell Longev. 2021;1–27.

  50. Setyopranoto I, Malueka RG, Panggabean AS, Widyadharma IPE, Sadewa AH, Lamsudin R, et al. Association between increased matrix metalloproteinase-9 (MMP-9) levels with hyperglycaemia incidence in acute ischemic stroke patients. Open Access Maced J Med Sci. 2018;6(11):2067–72.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Awooda HA. Pathophysiology of cerebral ischemia: role of oxidative/nitrosative stress. J Biosci Med. 2019;7:20–8.

    CAS  Google Scholar 

  52. Li W, Yang S. Targeting oxidative stress for the treatment of ischemic stroke: upstream and downstream therapeutic strategies. Brain Circ. 2016;2:153–63.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Liu Z, Zhu Z, Zhao J, Ren W, Cai Y, Wang Q, et al. Malondialdehyde: a novel predictive biomarker for post-stroke depression. J Affect Disord. 2017;220:95–101.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

This research did not receive any specific Grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Neurology, Dr. Kariadi Hospital/Faculty of Medicine Diponegoro University, Dr. Sutomo 16, Semarang, 50244, Indonesia

    Dodik Tugasworo, Aditya Kurnianto, Retnaningsih Retnaningsih, Yovita Andhitara, Rahmi Ardhini & Jethro Budiman

  2. Department of Biomedical Science, Faculty of Medicine Diponegoro University, Semarang, Indonesia

    Awal Prasetyo

Authors
  1. Dodik Tugasworo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Awal Prasetyo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aditya Kurnianto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Retnaningsih Retnaningsih
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yovita Andhitara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rahmi Ardhini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jethro Budiman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

DT, AP, and AK: conceived the original idea and collected data; RR: collected data and proof outline; YA, RA, and JB: wrote the manuscript with the support of other authors. All authors have read and approved the final manuscript to be published.

Corresponding author

Correspondence to Dodik Tugasworo.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests/conflicts of interest concerning this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tugasworo, D., Prasetyo, A., Kurnianto, A. et al. Malondialdehyde (MDA) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in ischemic stroke: a systematic review. Egypt J Neurol Psychiatry Neurosurg 59, 87 (2023). https://doi.org/10.1186/s41983-023-00688-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41983-023-00688-6

Keywords